Literature DB >> 17964860

The effect of subcutaneous naloxone on experimentally induced pain.

Lucy J Robertson1, Geoffrey R Hammond, Peter D Drummond.   

Abstract

UNLABELLED: The heat pain threshold was assessed in 32 healthy participants after a mild burn on the dorsal surface of each hand, after injection of an opioid antagonist (80 microg naloxone) or vehicle alone (0.2 mL saline) into the burnt skin of 1 hand, and after repeated painful immersion of this hand in cold water for up to 180 seconds. We hypothesized that sensitivity to heat would decrease at the burn-injured site after the immersions, due to local release of opioids into the burnt skin. Naloxone augmented cold-induced pain during the immersions in participants who tolerated the longest immersions, implying that release of endogenous opioids suppressed cold-pain. After the immersions, sensitivity to heat decreased at the burn-injured site in the immersed hand, but naloxone did not block this effect. Instead, naloxone altered sensitivity to heat in unburnt skin, implying that thermal hyperalgesia at sites of burn injury masked the modulatory effects of opioids. In particular, naloxone blocked a decrease in sensitivity to heat at an unburnt site on the contralateral hand of participants who tolerated the longest immersions, consistent with central or systemic opioid release. Naloxone reduced sensitivity to heat at unburnt sites in participants who tolerated medium-length immersions, suggesting that an increase in systemic or central opioid activity evoked thermal hyperalgesia in this group. In addition, in a small group of participants who tolerated only brief immersions, naloxone blocked decreases in sensitivity to heat at an unburnt site in the immersed hand. These findings suggest that repeated painful immersions trigger local opioid release in participants who tolerate only brief immersions, and elicit central or systemic opioid release in participants who tolerate longer immersions. PERSPECTIVE: This article demonstrates that repeated immersion of the hand in painfully cold water increases opioid activity and that the increase in opioid activity exerts multiple opposing effects on sensitivity to heat. Individual differences in the response to opioids might contribute to individual differences in pain tolerance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964860     DOI: 10.1016/j.jpain.2007.08.008

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  6 in total

1.  Regulation of spinal dynorphin 1-17 release by endogenous pituitary adenylyl cyclase-activating polypeptide in the male rat: relevance of excitation via disinhibition.

Authors:  Nai-Jiang Liu; Stephen A Schnell; Stefan Schulz; Martin W Wessendorf; Alan R Gintzler
Journal:  J Pharmacol Exp Ther       Date:  2010-10-25       Impact factor: 4.030

2.  Responsiveness of C neurons in rat dorsal root ganglion to 5-hydroxytryptamine-induced pruritic stimuli in vivo.

Authors:  Junichi Hachisuka; Hidemasa Furue; Masutaka Furue; Megumu Yoshimura
Journal:  J Neurophysiol       Date:  2010-05-19       Impact factor: 2.714

3.  Stress and pain: modality-specific opioid mediation of stress-induced analgesia.

Authors:  Mustafa al'Absi; Motohiro Nakajima; Stephen Bruehl
Journal:  J Neural Transm (Vienna)       Date:  2021-08-17       Impact factor: 3.850

Review 4.  Endogenous opioid antagonism in physiological experimental pain models: a systematic review.

Authors:  Mads U Werner; Manuel P Pereira; Lars Peter H Andersen; Jørgen B Dahl
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

5.  Interaction between Analgesic Effect of Nano and Conventional size of Zinc Oxide and Opioidergic System Activity in Animal Model of Acute Pain.

Authors:  Mahnaz Kesmati; Mozhgan Torabi
Journal:  Basic Clin Neurosci       Date:  2014

6.  Pharmacological fMRI provides evidence for opioidergic modulation of discrimination of facial pain expressions.

Authors:  Yili Zhao; Markus Rütgen; Lei Zhang; Claus Lamm
Journal:  Psychophysiology       Date:  2020-11-03       Impact factor: 4.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.